Daniel W Shrey1, Olivia Kim McManus2, Rajsekar Rajaraman3, Hernando Ombao4, Shaun A Hussain3, Beth A Lopour5. 1. Division of Neurology, Children's Hospital Orange County, Orange, CA, USA; Department of Pediatrics, University of California, Irvine, CA, USA. 2. Division of Neurology, Children's Hospital Orange County, Orange, CA, USA; Division of Pediatric Neurology, University of California, San Diego, CA, USA. 3. Division of Pediatric Neurology, University of California, Los Angeles, CA, USA. 4. Department of Statistics, University of California, Irvine, CA, USA; Statistics Program, King Abdullah University of Science and Technology, Saudi Arabia. 5. Department of Biomedical Engineering, University of California, Irvine, CA, USA. Electronic address: beth.lopour@uci.edu.
Abstract
OBJECTIVE: Epileptic spasms (ES) are associated with pathological neuronal networks, which may underlie characteristic EEG patterns such as hypsarrhythmia. Here we evaluate EEG functional connectivity as a quantitative marker of treatment response, in comparison to classic visual EEG features. METHODS: We retrospectively identified 21 ES patients and 21 healthy controls. EEG data recorded before treatment and after ≥10 days of treatment underwent blinded visual assessment, and functional connectivity was measured using cross-correlation techniques. Short-term treatment response and long-term outcome data were collected. RESULTS: Subjects with ES had stronger, more stable functional networks than controls. After treatment initiation, all responders (defined by cessation of spasms) exhibited decreases in functional connectivity strength, while an increase in connectivity strength occurred only in non-responders. There were six subjects with unusually strong pre-treatment functional connectivity, and all were responders. Visually assessed EEG features were not predictive of treatment response. CONCLUSIONS: Changes in network connectivity and stability correlate to treatment response for ES, and high pre-treatment connectivity may predict favorable short-term treatment response. Quantitative measures outperform visual analysis of the EEG. SIGNIFICANCE: Functional networks may have value as objective markers of treatment response in ES, with potential to facilitate rapid identification of personalized, effective treatments.
OBJECTIVE:Epileptic spasms (ES) are associated with pathological neuronal networks, which may underlie characteristic EEG patterns such as hypsarrhythmia. Here we evaluate EEG functional connectivity as a quantitative marker of treatment response, in comparison to classic visual EEG features. METHODS: We retrospectively identified 21 ESpatients and 21 healthy controls. EEG data recorded before treatment and after ≥10 days of treatment underwent blinded visual assessment, and functional connectivity was measured using cross-correlation techniques. Short-term treatment response and long-term outcome data were collected. RESULTS: Subjects with ES had stronger, more stable functional networks than controls. After treatment initiation, all responders (defined by cessation of spasms) exhibited decreases in functional connectivity strength, while an increase in connectivity strength occurred only in non-responders. There were six subjects with unusually strong pre-treatment functional connectivity, and all were responders. Visually assessed EEG features were not predictive of treatment response. CONCLUSIONS: Changes in network connectivity and stability correlate to treatment response for ES, and high pre-treatment connectivity may predict favorable short-term treatment response. Quantitative measures outperform visual analysis of the EEG. SIGNIFICANCE: Functional networks may have value as objective markers of treatment response in ES, with potential to facilitate rapid identification of personalized, effective treatments.
Authors: Mark Fiecas; Hernando Ombao; Dan van Lunen; Richard Baumgartner; Alexandre Coimbra; Dai Feng Journal: Neuroimage Date: 2012-09-29 Impact factor: 6.556
Authors: Shaun A Hussain; Grace Kwong; John J Millichap; John R Mytinger; Nicole Ryan; Joyce H Matsumoto; Joyce Y Wu; Jason T Lerner; Raman Sankar Journal: Epilepsia Date: 2014-11-10 Impact factor: 5.864
Authors: Catherine J Chu; Mark A Kramer; Jay Pathmanathan; Matt T Bianchi; M Brandon Westover; Lauren Wizon; Sydney S Cash Journal: J Neurosci Date: 2012-02-22 Impact factor: 6.167
Authors: Peter Fransson; Beatrice Skiöld; Sandra Horsch; Anders Nordell; Mats Blennow; Hugo Lagercrantz; Ulrika Aden Journal: Proc Natl Acad Sci U S A Date: 2007-09-18 Impact factor: 11.205
Authors: Scott T Demarest; Renée A Shellhaas; William D Gaillard; Cynthia Keator; Katherine C Nickels; Shaun A Hussain; Tobias Loddenkemper; Anup D Patel; Russell P Saneto; Elaine Wirrell; Iván Sánchez Fernández; Catherine J Chu; Zachary Grinspan; Courtney J Wusthoff; Sucheta Joshi; Ismail S Mohamed; Carl E Stafstrom; Cynthia V Stack; Elissa Yozawitz; Judith S Bluvstein; Rani K Singh; Kelly G Knupp Journal: Epilepsia Date: 2017-11-03 Impact factor: 5.864
Authors: William Stacey; Mark Kramer; Kristin Gunnarsdottir; Jorge Gonzalez-Martinez; Kareem Zaghloul; Sara Inati; Sridevi Sarma; Jennifer Stiso; Ankit N Khambhati; Danielle S Bassett; Rachel J Smith; Virginia B Liu; Beth A Lopour; Richard Staba Journal: Epilepsy Res Date: 2019-12-09 Impact factor: 3.045
Authors: Yan Dong; Ruijuan Xu; Yaodong Zhang; Yali Shi; Kaixian Du; Tianming Jia; Jun Wang; Fang Wang Journal: Front Pediatr Date: 2022-05-12 Impact factor: 3.569
Authors: Peter E Davis; Kush Kapur; Rajna Filip-Dhima; Sara K Trowbridge; Elaina Little; Andrew Wilson; Andrew Leuchter; Elizabeth M Bebin; Darcy Krueger; Hope Northrup; Joyce Y Wu; Mustafa Sahin; Jurriaan M Peters Journal: Epilepsia Date: 2019-07-12 Impact factor: 6.740
Authors: Blanca Romero Milà; Kavyakantha Remakanthakurup Sindhu; John R Mytinger; Daniel W Shrey; Beth A Lopour Journal: Front Neurol Date: 2022-07-28 Impact factor: 4.086